EXAGEN INC (XGN) Stock News
NASDAQ:XGN - Nasdaq - US30068X1037 - Common Stock - Currency: USD
XGN Latest News and Analysis
Exagen Inc. to Participate in Upcoming Investor Conferences
Exagen Inc. to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management...
Tuesday's session: top gainers and losers
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing...
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient care
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for...
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Significant enhancements will equip clinicians with even more diagnostic clarity in the treatment of patients with autoimmune disease
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Significant enhancements will equip clinicians with even more diagnostic clarity in the treatment of patients with autoimmune disease...
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Exagen Inc. Reports Third Quarter 2024 Results
Exagen Inc. Reports Third Quarter 2024 Results
Expanded AVISE® CTD trailing twelve-month average selling priceReduced Adjusted EBITDA loss for first three quarters of 2024Revenue in line with...
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
CARLSBAD, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results...
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
CARLSBAD, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance...
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its...
Market Mayhem Winners: What Stocks Are Up Today?
What stocks are up today? It’s a natural question following the implosion of the global markets and the answer might surprise you.
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exagen (NASDAQ:XGN) just reported results for the second quarter of 2024.Exagen...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported...
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its...
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
CARLSBAD, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions announced today the...
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exagen (NASDAQ:XGN) just reported results for the first quarter of 2024.Exagen ...
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported...
Exagen Announces Campaign for Lupus Awareness Month
Exagen to Announce First Quarter 2024 Results on May 13, 2024
Exagen to Announce First Quarter 2024 Results on May 13, 2024
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results...
Exagen Inc. Announces Changes to the Board of Directors
Exagen Inc. Announces Changes to the Board of Directors
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced...